High immunohistochemical expression of TGF-β1 predicts a poor prognosis in cervical cancer patients who harbor enriched endoglin microvessel density

International Journal of Gynecological Pathology

Volumn 31, Issue 5, 2012, Pages 482-489

  Lin, Hao ^a   Huang, Chao Cheng ^a   Ou, Yu Che ^a   Huang, Eng Yen ^a   Changchien, Chan Chao ^a   Tseng, Chih Wen ^b   Fu, Hung Chun ^a   Wu, Chen Hsuan ^a   Li, Chia Jung ^a   Ma, Yen Ying ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cervical cancer; Concurrent chemoradiation; Endoglin; TGF b1

Indexed keywords

CISPLATIN; ENDOGLIN; FLUOROURACIL; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD31; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTORS, CELL SURFACE; TRANSFORMING GROWTH FACTOR BETA1; UTERINE CERVICAL NEOPLASMS;

EID: 84864842756     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31824c23a4     Document Type: Article

References (25)

1. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interact with the signaling receptor complex of multiple members of the transforming growth factor-h superfamily. J Biol Chem 1999;274:584-94
2. Wang JM, Kumar S, Pye D, et al. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 1993;54:363-70 (Pubitemid 23169671)
3. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-37
4. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-24
5. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84: 1875-7
6. Brewer CA, Setterdahl JJ, Li MJ, et al. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 2000;96:224-8 (Pubitemid 30447343)
7. Chien CY, Su CY, Hwang CF, et al. High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 2006;94:413-7
8. Rossmanith W, Schulte-Hermann R. Biology of transforming growth factor b in hepatocarcinogenesi. Microsc Res Tech 2001;52:430-6
9. Weller M, Wick W, Platten M. Role of TGFb in oncogenesis. Microsc Res Tech 2001;52:353-63
10. Taiwan cancer registry, Bureau of Health Promotion, Department of Health, Republic of China. Female Genital Tract Malignancy; 2009. Available at: http://tcr.cph.ntu.edu.tw/main.php?Page=A5)
11. Brizel DM, Dodge RK, Clough RW, et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-7
12. Sanchez-Elsner T, Botella LM, Velasco B, et al. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 2002;277:43799-808 (Pubitemid 36157800)
13. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
14. Benetti A, Berenzi A, Gambarotti M, et al. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Res 2008;68:8626-34
15. Brewer CA, Setterdahl JJ, Li MJ, et al. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 2000;96:224-8 (Pubitemid 30447343)
16. Zijlmans HJ, Fleuren GJ, Hazelbag S, et al. Expression of endoglin (CD105) in cervical cancer. Br J Cancer 2009; 100:1617-26
17. Randall LM, Monk BJ, Darcy KM, et al. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol 2009;112: 583-9
18. Bellone G, Gramigni C, Vizio B, et al. Abnormal expression of Endoglin and its receptor complex (TGF-b1 and TGF-b receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Int J Oncol 2010;37: 1153-65
19. Daniel P, Wagrowska-Danilewicz M, Danilewicz M, et al. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. Int J Colorectal Dis 2007;22:1165-72 (Pubitemid 47304784)
20. Vagenas K, Spyropoulos C, Gavala V, et al. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res 2007;139:182-8 (Pubitemid 46551168)
21. Teicher BA. Malignant cells, directors of the malignant process; role of transforming growth factor-beta. Cancer Metastasis Rev 2001;20:133-43 (Pubitemid 34074689)
22. Pinedo HM, Verheul HM, D'Amato RJ, et al. Involvement of platelets in tumor angiogenesis? Lancet 1998;352:1775-77
23. Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 2004;63: 226-35 (Pubitemid 38900837)
24. Gungor T, Kanat-Pektas M, Sucak A, et al. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet 2009;279:53-6
25. Hernandez E, Donohue KA, Anderson LL, et al. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2000;78:137-42. (Pubitemid 30650343)